BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. BD’s 40,000 associates in 50 countries work with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. bd.com
At Beckman Coulter, we are dedicated to advancing and optimizing the laboratory. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. We have a vital role: our focus on innovation, reliability and efficiency has led us to become the partner of choice for clinical, research and industrial customers around the globe.
Beckman Coulter Life Sciences delivers innovative and trusted scientific solutions across the globe for laboratory customers in a wide variety of settings: universities, government, biotechnology and pharmaceutical companies, hospitals, and commercial laboratories. By innovating new processes and technologies, we’re challenging conventional wisdom to develop the best, most widely trusted laboratory solutions available in the market today.
Bio-Rad Laboratories (NYSE: BIO and BIOb) continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,300 employees and serves more than 100,000 research and industry customers worldwide through the company’s global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, and cell culture. Our 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 1,400 employees in 25 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.
FlowJo, LLC is a privately-owned life sciences informatics company in Ashland, Oregon. Based on technology developed at Stanford, the company was founded in 1997 and provides the leading analysis platform for single-cell flow cytometry analysis. Their software innovations enable collaboration, discovery, high-throughput analysis, and data leadership in single-cell biology. For more information, see www.flowjo.com.
Sony Biotechnology Inc. is dedicated to helping the immunology community of scientists, researchers, laboratory professionals, and institutions achieve the best scientific results possible. By leveraging Sony’s comprehensive expertise in electronics innovation and design and with our technological assets we are accelerating development of next-generation cell analysis systems. We bring a unique perspective to science’s high-level instrumentation and are creating innovative products to address our customer’s challenges.
ACEA Biosciences is a privately-owned biotechnology company pioneering in the development and commercialization of advanced research instrumentation for the life sciences. ACEA’s mission is to transform cell analysis, by providing innovative products and advanced solutions to the basic research, biotech, and pharmaceutical communities. ACEA launched its first product for real-time, label-free cell-based assays in 2004. Today, the company has a product line of seven instruments, which includes ACEA’s xCELLigence® line of impedance-based, label-free, real time cell analysis systems, and NovoCyte™ flow cytometers, which are used in pre-clinical drug discovery and development, toxicity testing, drug safety, and basic academic research.
Sysmex is a global market leader in the development and implementation of clinical diagnostic and health IT products and services for laboratories, hospitals and healthcare organisations.
We deliver total solutions in the field of clinical laboratory testing, including haematology, haemostasis, urinalysis, clinical chemistry, immunoassay system, flow cytometry, liquid biopsy and life science. Supplying products and services to customers in more than 150 countries, Sysmex is the market leader in haematology and coagulation instrumentation worldwide.
By working together with our customers and business partners, Sysmex is committed to our mission of shaping the advancement of healthcare.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer.
Combining precision with performance, the Invitrogen™ Attune™ NxT Flow Cytometer is a benchtop analyzer configurable with up to 4 lasers and 16 parameters while offering superior speed and clog-resistant engineering. This instrument is designed to help researchers gather data like never before and achieve superior results.
Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. www.thermofisher.com
The Singapore Immunology Network (SIgN) was launched on 10 February 2006 by the Agency for Science, Technology and Research (A*STAR) with the aim of expanding and strengthening immunology research in Singapore. In January 2008, 6000m2 of new laboratory and office space was inaugurated as the home of SIgN, in the Immunos building at Biopolis.
The mandate of SIgN is to advance human immunology research and participate in international efforts to combat major health problems. Our Research Programmes focus on investigating immunity during infections and inflammatory conditions, including cancer, using both mouse models and human tissues. SIgN researchers are well-supported by cutting-edge technology platforms established centrally within the institute. Such key capabilities include SIgN’s Clinical Immunomonitoring Platform that provides access to a full suite of state-of-the-art Immunomonitoring technologies conducting fully integrated studies.
Since its launch SIgN has grown rapidly, and currently includes around 200 scientists from 25 different countries of the world, working under 21 renowned Principal Investigators. Our scientists’ work is supported by cutting edge technological research platforms and core services.
Biospecifix is a niche healthcare company that focuses on provision of specialty products and services to Clinical Pathology and Research laboratories.
Biospecifix is recognised in the industry for providing outstanding customer service, high quality flow cytometry products and support.
Biospecifix is the exclusive distributor of Cytognos flow cytometry products including Euroflow Screening tubes and Infinicyt software.
At Cyto Asia 2017 please visit us at booth S4 and we will be launching the following new Cytognos products:
Infinicyt v2.0 – includes the new database and automated analysis features
Specific Myeloma products – MM-MRD Euroflow tube and the CD38 Multi-epitope antibody
New Primary Immunodeficiency tube
BioLegend develops and manufactures highly recognized, world‐class anbodies and reagents at an outstanding value to customers for biomedical research. Our broad product portfolio includes flow cytometry, cell biology, and biofuntional molecules for research in immunology, neuroscience, cancer, cell biology, stem cells, and more. Our aggressive product development program, accomplished through technology licensing, collaborations, and internal research and development, has produced a product offering of over 17,000 products, which have been collectively cited in over 25,000 peer‐reviewed journals. BioLegend also offers a wide range of custom services including assay development, sample testing, and conjugation. BioLegend’s reagents are supported by superior customer service and a quality management system dedicated to continuous improvement that is certified for ISO 9001:2008 and ISO 13485:2003.
De Novo Software is a leading provider of flow and image cytometry analysis software. Its primary product, FCS
Express™, is used by thousands of laboratories worldwide for research purposes, and dozens of clinical laboratories for high throughput clinical analysis. As the first third‐party flow analysis software listed with the FDA for in‐vitro diagnostic use, and with full 21 CFR Part 11 compliance features, FCS Express is the analysis tool of
choice for the clinical laboratory. In addition, De Novo Software has extensive experience creating custom data
analysis solutions and integrating with large scale LIS/HIS. For more information, please visit www.denovosoftware.com.
Merck KGaA, Darmstadt, Germany is a leading science and technology company for innovative and top-quality high-tech products in healthcare, life science and performance materials.
With a catalog of more than 300,000 products, our Life Science business delivers many of the most highly-respected brands in the industry, such as Millipore, Milli-Q, SAFC and BioReliance. Our offering covers every step of the biotech production chain, creating a complete end-to-end workflow with enhanced customer service, a simplified interface and a leading distribution platform.
Our innovative portfolio, well-balanced geographic reach, and industry leading capabilities uniquely positions us to anticipate and deliver on customer needs. Our Life Science business brings together the legacy expertise of the life science portfolio of Merck KGaA, Darmstadt, Germany, and Sigma-Aldrich, which was acquired by us in 2015.